|Articles|May 1, 2000

May 2000
Volume 6
Issue 5

Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Author(s)Phillip B. Amidon, MD, Rhonda Jankovich, RN, BSN, Cheryl A. Stoukides, PharmD

Download PDF: Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Articles in this issue

about 26 years ago

Article

Training Tomorrow's Clinicians Today - Managed Care Essentials: A Process for Curriculum Development

about 26 years ago

Article

Relationship of Hemoglobin A1C, Age of Diabetes Diagnosis, and Ethnicity to Clinical Outcomes and Medical Costs in a Computer-Simulated Cohort of Persons with Type 2 Diabetes

about 26 years ago

Article

Disease Management Program Improves Asthma Outcomes

about 26 years ago

Article

Prescribing Medications for Geriatric Patients in the Managed Care Setting

about 26 years ago

Article

The Inpatient Specialist: What is the Difference?

about 26 years ago

Article

Teaching Managed Care Principles: We Need to Do Better

about 26 years ago

Article

The Impact of an Inpatient Physician Program on Quality, Utilization, and Satisfaction

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS